Young Adult Latino Testicular Cancer Survivors: a Pilot Study of Goal-Focused Emotion Regulation Therapy (GET)

Completed · Not applicable

Conditions studied: Testicular Cancer

In brief

Testicular cancer diagnosis and treatment, especially given its threat to sexuality and reproductive health, can be distressing in the formative period of young adulthood. Responsive to the need for feasible, effective, and scalable interventions that meet the needs of ethnic minority men, 35 Hispanic/Latino young adults (ages 18-39) with testicular cancer will receive 6 sessions of GET. We will evaluate primary and secondary outcomes at baseline, post-treatment, and 3-month follow-up. In addition, identified biomarkers will be assessed at baseline and post-intervention.

Key facts

Study ID

NCT07615998

Run by

University of California, Irvine

People needed

35

Starts

2020-08-05

Expected to finish

2023-08-14

Last updated by the study team

2026-05-29

Who can join

Age: 18 and older, up to 39. Sex: male. Healthy volunteers: not accepted.

You may qualify if…

• Age 18 to 39 years at time of consent
• A confirmed diagnosis of testis cancer
• Completion of primary medical treatment for testicular cancer within 4 years at time of consent
• Hispanic/Latino identification (self or cancer registry confirmed)
• A score of < 1.8 on the goal navigation scale or < 0.6 on the goal facility scale of the CAYA or >4 on the Distress Thermometer
• English or Spanish fluency, as per medical record documenting preferred language or in the judgment of the investigator
• Able to perform informed consent

You may not qualify if…

• Lifetime history of psychiatric of cognitive disturbance as per self-report or medical record
• In the judgment of the consenting professional, is unable to provide informed consent and complete study sessions and assessment
• As per self-report, has medical conditions that affect the immune system and would confound immune evaluation (e.g., autoimmune disorder, inflammatory disease; uncontrolled thyroid disease; active infection; myocardial infarction or stroke in the last 6 months; Type I diabetes; acute hepatitis; recent vaccination for viral disease)
• Regular smoker (daily use)

Where it is running

• University of California, Irvine — Irvine, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.